DORM: Sales grew 3.3%; FY guidance narrowed as tariff-related pricing weighed on EPS comparisons

What happened

Third-quarter sales rose 3.3% from a year earlier, while diluted and adjusted earnings per share declined amid a tougher comparison with tariff-related pricing benefits in the third quarter of 2025. Full-year 2026 guidance was narrowed, and share repurchases reached a record $112 million in the first nine months.

Confirmed

Global impact / market context

Falling earnings per share despite sales growth means more of each sale went to costs, or the earlier tariff-related pricing boost faded, which weighs on profit per sale. Narrowed guidance gives investors a tighter range, while $112 million of buybacks reduced share count and supported per-share figures.

Analyst inference

A tougher comparison with tariff-related pricing benefits a year earlier suggests price increases lifted prior results and are no longer helping as much. The gap between sales growth and falling earnings per share signals cost pressure, which affects how investors judge future profit and cash available.

Analyst inference

What to watch

1. Full-year 2026 guidance was narrowed, so the company's updated expected range for the year is a specific figure investors can compare with actual quarterly results. Confirmed
2. Watch whether tariff-related pricing benefits keep fading in coming quarters, which would make year-earlier comparisons harder and could keep earnings per share under pressure. Analyst inference
3. Watch whether record buybacks of $112 million continue, because fewer shares can lift earnings per share even when total profit is flat. Analyst inference

Evidence

• Original source link unavailable